Xu L - Search Results

1

Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.

Taylor S, Cane P, Hué S, Xu L, Wrin T, Lie Y, Hellmann N, Petropoulos C, Workman J, Ratcliffe D, Choudhury B, Pillay D. Taylor S, et al. Among authors: xu l. AIDS Res Hum Retroviruses. 2003 May;19(5):353-61. doi: 10.1089/088922203765551700. AIDS Res Hum Retroviruses. 2003. PMID: 12803994

2

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients.

Xu L, Hué S, Taylor S, Ratcliffe D, Workman JA, Jackson S, Cane PA, Pillay D. Xu L, et al. AIDS. 2002 Aug 16;16(12):1684-6. doi: 10.1097/00002030-200208160-00016. AIDS. 2002. PMID: 12172092

3

Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41.

Xu L, Pozniak A, Wildfire A, Stanfield-Oakley SA, Mosier SM, Ratcliffe D, Workman J, Joall A, Myers R, Smit E, Cane PA, Greenberg ML, Pillay D. Xu L, et al. Antimicrob Agents Chemother. 2005 Mar;49(3):1113-9. doi: 10.1128/AAC.49.3.1113-1119.2005. Antimicrob Agents Chemother. 2005. PMID: 15728911 Free PMC article.

4

Genetic diversity of integrase (IN) sequences in antiretroviral treatment-naive and treatment-experienced HIV type 2 patients.

Xu L, Anderson J, Ferns B, Cook P, Wildfire A, Workman J, Graham S, Smit E. Xu L, et al. AIDS Res Hum Retroviruses. 2008 Jul;24(7):1003-7. doi: 10.1089/aid.2007.0303. AIDS Res Hum Retroviruses. 2008. PMID: 18593344

5

Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.

Xu L, Anderson J, Garrett N, Ferns B, Wildfire A, Cook P, Workman J, Graham S, Smit E. Xu L, et al. AIDS Res Hum Retroviruses. 2009 Aug;25(8):843-7. doi: 10.1089/aid.2009.0039. AIDS Res Hum Retroviruses. 2009. PMID: 19618998

6

Raltegravir treatment response in an HIV-2 infected patient: a case report.

Garrett N, Xu L, Smit E, Ferns B, El-Gadi S, Anderson J. Garrett N, et al. Among authors: xu l. AIDS. 2008 May 31;22(9):1091-2. doi: 10.1097/QAD.0b013e3282f9b165. AIDS. 2008. PMID: 18520356 No abstract available.

7

Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.

McAuliffe B, Falk P, Chen J, Chen Y, Sit SY, Swidorski J, Hartz RA, Xu L, Venables B, Sin N, Meanwell NA, Regueiro-Ren A, Wensel D, Hanumegowda U, Krystal M. McAuliffe B, et al. Among authors: xu l. Viruses. 2024 Sep 24;16(10):1508. doi: 10.3390/v16101508. Viruses. 2024. PMID: 39459843 Free PMC article.

8

A prediction method and evaluation for assessing guide-supported dental implant accuracy.

Xu L, Wu J, Chen L, Gao H, Zhu X, Yang G, Chen Y. Xu L, et al. Comput Methods Biomech Biomed Engin. 2025 Feb;28(2):188-196. doi: 10.1080/10255842.2023.2284092. Epub 2023 Nov 20. Comput Methods Biomech Biomed Engin. 2025. PMID: 39808451

9

Preferred and Actual Location of Death in Adolescents and Young Adults With Cancer.

Odejide OO, Cernik C, Uno H, Fisher L, Xu L, Laurent CA, Cannizzaro N, Munneke J, Cooper RM, Lakin JR, Schwartz CM, Casperson M, Altschuler A, Wiener L, Kushi L, Chao CR, Mack JW. Odejide OO, et al. Among authors: xu l. JAMA Netw Open. 2025 Jan 2;8(1):e2454000. doi: 10.1001/jamanetworkopen.2024.54000. JAMA Netw Open. 2025. PMID: 39808433

10

Baicalein attenuates ovalbumin-induced allergic rhinitis through the activation of nuclear receptor subfamily 4 group a member 1.

Xu Y, Xu L, Jian X, Wang Q, Li Z, Ge H. Xu Y, et al. Among authors: xu l. Immunol Res. 2025 Jan 14;73(1):32. doi: 10.1007/s12026-024-09590-6. Immunol Res. 2025. PMID: 39808359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,982 results

Search Page

Filters